These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

150 related articles for article (PubMed ID: 29261797)

  • 1. Correction: Identifying Optimal Vaccination Strategies for Serogroup A Neisseria meningitidis Conjugate Vaccine in the African Meningitis Belt.
    Tartof S; Cohn A; Tarbangdo F; Djingarey MH; Messonnier N; Clark TA; Kambou JL; Novak R; Diomandé FVK; Medah I; Jackson ML
    PLoS One; 2017; 12(12):e0190188. PubMed ID: 29261797
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The Establishment and Diversification of Epidemic-Associated Serogroup W Meningococcus in the African Meningitis Belt, 1994 to 2012.
    Retchless AC; Hu F; Ouédraogo AS; Diarra S; Knipe K; Sheth M; Rowe LA; Sangaré L; Ky Ba A; Ouangraoua S; Batra D; Novak RT; Ouédraogo Traoré R; Wang X
    mSphere; 2016; 1(6):. PubMed ID: 27904879
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Meningococcal serogroup W135 in the African meningitis belt: epidemiology, immunity and vaccines.
    Mueller JE; Borrow R; Gessner BD
    Expert Rev Vaccines; 2006 Jun; 5(3):319-36. PubMed ID: 16827617
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Laboratory evaluation of a rapid diagnostic test for Neisseria meningitidis serogroup A.
    Terrade A; Collard JM; Nato F; Taha MK
    Trans R Soc Trop Med Hyg; 2013 Jul; 107(7):460-1. PubMed ID: 23687106
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Clonal expansion of Neisseria meningitidis W135. Epidemiological implications for the African meningitis belt].
    du Châtelet IP; Alonso JM; Taha MK
    Bull Soc Pathol Exot; 2002 Dec; 95(5):323-4; discussion 324-5. PubMed ID: 12696368
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A randomized trial to assess safety and immunogenicity of alternative formulations of a quadrivalent meningococcal (A, C, Y, and W-135) tetanus protein conjugate vaccine in toddlers.
    McVernon J; Nolan T; Richmond P; Reynolds G; Nissen M; Lambert SB; Marshall H; Papa T; Rehm C
    Pediatr Infect Dis J; 2012 Jan; 31(1):e15-23. PubMed ID: 22094636
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The Diversity of Meningococcal Carriage Across the African Meningitis Belt and the Impact of Vaccination With a Group A Meningococcal Conjugate Vaccine.
    MenAfriCar consortium
    J Infect Dis; 2015 Oct; 212(8):1298-307. PubMed ID: 25858956
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Evolving meningococcal immunization strategies.
    Sáfadi MA; Bettinger JA; Maturana GM; Enwere G; Borrow R;
    Expert Rev Vaccines; 2015 Apr; 14(4):505-17. PubMed ID: 25494168
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Correction: A Seroepidemiological Study of Serogroup A Meningococcal Infection in the African Meningitis Belt.
    Manigart O; Trotter C; Findlow H; Aseffa A; Mihret W; Moti Demisse T; Yeshitela B; Osei I; Hodgson A; Quaye SL; Sow S; Coulibaly M; Diallo K; Traore A; Collard JM; Moustapha Boukary R; Djermakoye O; Mahamane AE; Jusot JF; Sokhna C; Alavo S; Doucoure S; Ba EH; Dieng M; Diallo A; Daugla DM; Omotara B; Chandramohan D; Hassan-King M; Nascimento M; Woukeu A; Borrow R; Stuart JM; Greenwood B
    PLoS One; 2016; 11(7):e0158938. PubMed ID: 27379429
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Emergence of serogroup X meningococcal disease in Africa: need for a vaccine.
    Xie O; Pollard AJ; Mueller JE; Norheim G
    Vaccine; 2013 Jun; 31(27):2852-61. PubMed ID: 23623866
    [TBL] [Abstract][Full Text] [Related]  

  • 11. An outer membrane vesicle vaccine for prevention of serogroup A and W-135 meningococcal disease in the African meningitis belt.
    Norheim G; Tunheim G; Næss LM; Kristiansen PA; Caugant DA; Rosenqvist E
    Scand J Immunol; 2012 Aug; 76(2):99-107. PubMed ID: 22537024
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Response Strategies against Meningitis Epidemics after Elimination of Serogroup A Meningococci, Niger.
    Maïnassara HB; Paireau J; Idi I; Pelat JP; Oukem-Boyer OO; Fontanet A; Mueller JE
    Emerg Infect Dis; 2015 Aug; 21(8):1322-9. PubMed ID: 26196461
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Neisseria meningitidis serogroup A vaccines: an overview.
    Vergnano S; Heath P
    Expert Rev Vaccines; 2003 Aug; 2(4):571-82. PubMed ID: 14711341
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Epidemic meningitis due to Group A Neisseria meningitidis in the African meningitis belt: a persistent problem with an imminent solution.
    Marc LaForce F; Ravenscroft N; Djingarey M; Viviani S
    Vaccine; 2009 Jun; 27 Suppl 2():B13-9. PubMed ID: 19477559
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Salivary and Serum Antibody Response Against Neisseria meningitidis After Vaccination With Conjugate Polysaccharide Vaccines in Ethiopian Volunteers.
    Bårnes GK; Workalemahu B; Kristiansen PA; Beyene D; Merdekios B; Fissiha P; Aseffa A; Caugant DA; Naess LM
    Scand J Immunol; 2016 Aug; 84(2):118-29. PubMed ID: 27219622
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Evaluation of the Pastorex meningitis kit for the rapid identification of Neisseria meningitidis serogroups A and W135.
    Djibo S; Njanpop Lafourcade BM; Boisier P; Moussa A; Kobo G; Sidikou F; Hien A; Bieboure G; Aguilera JF; Parent du Chatelet I; Gessner BD; Chanteau S
    Trans R Soc Trop Med Hyg; 2006 Jun; 100(6):573-8. PubMed ID: 16406096
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Technical Development of a New Meningococcal Conjugate Vaccine.
    Frasch CE; Kapre SV; Lee CH; Préaud JM
    Clin Infect Dis; 2015 Nov; 61 Suppl 5(Suppl 5):S404-9. PubMed ID: 26553667
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A serogroup A meningococcal polysaccharide vaccine: studies in the Sudan to combat cerebrospinal meningitis caused by Neisseria meningitidis group A.
    Erwa HH; Haseeb MA; Idris AA; Lapeyssonnie L; Sanborn WR; Sippel JE
    Bull World Health Organ; 1973; 49(3):301-5. PubMed ID: 4211056
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Trends and variations in the epidemiology of meningococcal disease in Kuwait 1987-2013.
    Husain EH; Barakat M; Al-Saleh M
    J Infect Public Health; 2015; 8(5):441-7. PubMed ID: 25779346
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Preclinical immunogenicity and functional activity studies of an A+W meningococcal outer membrane vesicle (OMV) vaccine and comparisons with existing meningococcal conjugate- and polysaccharide vaccines.
    Tunheim G; Arnemo M; Næss LM; Fjeldheim ÅK; Nome L; Bolstad K; Aase A; Mandiarote A; González H; González D; García L; Cardoso D; Norheim G; Rosenqvist E
    Vaccine; 2013 Dec; 31(51):6097-106. PubMed ID: 24120679
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.